+34 985 20 74 34
effichronic@ficyt.es
EFFICHRONIC

Menu

Skip to content
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter

Newsletter

EFFICHRONIC > Newsletter

  • Newsletter 1, December 2017
  • Newsletter 2, June 2018
  • Newsletter  3, December 2018
  • Newsletter  4, June 2019
  • Newsletter  5, January 2020

Upcoming Events

Feb
29
Sat
all-day Rare Disease Day
Rare Disease Day
Feb 29 all-day
Rare Disease Day
Rare Disease Day takes place on the last day of February each year. The main objective of Rare Disease Day is to raise awareness amongst the general public and decision-makers about rare diseases and their impact onRead More...
View Calendar
Add
  • Add to Timely Calendar
  • Add to Google
  • Add to Outlook
  • Add to Apple Calendar
  • Add to other calendar
  • Export to XML

Follow us

EFFICHRONICFollow

This activity is part of the project EFFICHRONIC (GA 738127) which has received funding from the European Union’s Health Programme (2014- 2020)

EFFICHRONIC
effichronicEFFICHRONIC@effichronic·
18 Feb

#InternationalAspergerDay falls on February 18th and aims to highlight the significance of Asperger syndrome in relation to the autism spectrum and the impact of this on individuals living with the condition.
#AspergerSyndrome
#autism #autistic
@AutismEurope
@inovar_autismo

Reply on Twitter 1229669628453912576Retweet on Twitter 1229669628453912576Like on Twitter 1229669628453912576Twitter 1229669628453912576
effichronicEFFICHRONIC@effichronic·
14 Feb

14 February is European Sexual Health Day. @WHO defines, the right to sexual and reproductive health as ‘a state of physical, emotional, mental and social well-being; not merely the absence of disease
#Sexual #Health #europeandayofsexualhealth#health @TopDoctors_UK

Reply on Twitter 1228221838448197632Retweet on Twitter 1228221838448197632Like on Twitter 1228221838448197632Twitter 1228221838448197632
effichronicEFFICHRONIC@effichronic·
14 Feb

#internationalchildhoodcancerday (#ICCD2020) was founded in 2002 #ICCD is celebrated around the world each year on February 15th.
#childhoodcancer #childhoodcancerawareness #pediatriccancer #cancer #gogold #ICCD2020
@WorldSIOP
@CancerPOINTE
@ChildhoodCancer
@IntChildCancer

Reply on Twitter 1228219825354309632Retweet on Twitter 1228219825354309632Like on Twitter 12282198253543096323Twitter 1228219825354309632
effichronicEFFICHRONIC@effichronic·
4 Feb

#WorldCancerDayis an international day marked on February 4 to raise awareness of cancer and to encourage its prevention, detection, and treatment.
@NCCN
@sloan_kettering
@OncoAlert
@uicc
#cancer #WorldCancerDay2020 #OncoAlert #IAmAndIWill

Reply on Twitter 1224598454229487616Retweet on Twitter 1224598454229487616Like on Twitter 12245984542294876161Twitter 1224598454229487616
effichronicEFFICHRONIC@effichronic·
31 Jan

What are the health benefits of exercise? #health #healthcare #exercise

Reply on Twitter 1223145136827371520Retweet on Twitter 1223145136827371520Like on Twitter 12231451368273715201Twitter 1223145136827371520
Load More...

Project Information

This website is part of the project ‘EFFICHRONIC’ which has received funding from the European Union’s Health Programme (2014-2020). Ref: 738127.  Co-funded by the Health Programme of the European Union

Project Title

Enhancing health systems sustainability by providing cost-efficiency data based interventions for chronic management in stratified population based on clinical and socio-economic determinants of health.

More Info

  • Sitemap
  • Contact
  • Data Protection
  • Disclaimer

 

Copyright © EFFICHRONIC
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
  • Home
  • About
  • Partners
    • CSPA-SESPA-FICYT
    • CHUM
    • EMC
    • EOG
    • QISMET
    • UVEG-Polibienestar
  • Work Packages
  • Deliverables
  • Publications
  • News
  • Intranet
  • Newsletter
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok